학술논문
Triplet therapy with palbociclib, taselisib, and fulvestrant in pik3ca-mutant breast cancer and doublet palbociclib and taselisib in pathway-mutant solid cancers
Document Type
Article
Author
Pascual, J.; Ring, A.; Okines, A.F.C.; Turner, N.C.; Cutts, R.J.; Herrera-Abreu, M.T.; Garcia-Murillas, I.; Pearson, A.; Hrebien, S.; Lim, J.S.J.; Macpherson, I.R.; Armstrong, A.C.; Gevensleben, H.; Proszek, P.Z.; Hubank, M.; Hills, M.; King, J.; Parmar, M.; Prout, T.; Finneran, L.; Turner, A.; Hall, E.; Lopez, J.S.; Malia, J.; Swales, K.E.; Ruddle, R.; Raynaud, F.I.; Yap, T.A.
Source
In: Cancer Discovery . (Cancer Discovery, January 2021, 11(1):92-107)
Subject
Language
English
ISSN
21598290
21598274
21598274